Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Ware · SciRah

Researcher profile · Semantic Scholar

R. Ware

Share profile

R. Ware — researcher profile on SciRah

h-index: 22
Works: 48
Citations: 2,677

Most-cited papers

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.
M. MacManus, R. Hicks, J. Matthews, A. Hogg +4 more
2001International Journal of Radiation Oncology, Biology, Physics307 citations
Semantic Scholar
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer
S. Porceddu, E. Jarmolowski, R. Hicks, R. Ware +4 more
2005Head and Neck262 citations Open access
Semantic Scholar
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
V. Kalff, R. Hicks, M. MacManus, D. Binns +4 more
2001Journal of Clinical Oncology238 citations
Semantic Scholar
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
R. Hicks, V. Kalff, M. MacManus, R. Ware +4 more
2001Journal of Nuclear Medicine232 citations
Semantic Scholar
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.
R. Hicks, V. Kalff, M. MacManus, R. Ware +3 more
2001Journal of Nuclear Medicine200 citations
Semantic Scholar
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
A. Wirth, J. Seymour, R. Hicks, R. Ware +6 more
2002American Journal of Medicine167 citations
Semantic Scholar
The Clinical Impact of 18F-FDG PET in Patients with Suspected or Confirmed Recurrence of Colorectal Cancer: A Prospective Study
V. Kalff, R. Hicks, R. Ware, A. Hogg +2 more
2002160 citations
Semantic Scholar
64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
R. Hicks, P. Jackson, G. Kong, R. Ware +16 more
2018Journal of Nuclear Medicine109 citations Open access
Semantic Scholar
Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.
F. Cachin, H. Prince, A. Hogg, R. Ware +1 more
2006Journal of Clinical Oncology98 citations Open access
Semantic Scholar
How do oncologists deal with incidental abnormalities on whole‐body fluorine‐18 fluorodeoxyglucose PET/CT?
Guo-Hui Wang, E. Lau, R. Shakher, D. Rischin +6 more
2007Cancer75 citations Open access
Semantic Scholar
Usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck
R. Ware, Jane P. Matthews, R. Hicks, S. Porceddu +4 more
2004Head and Neck74 citations
Semantic Scholar
The Cost-Effective Use of 18F-FDG PET in the Presurgical Evaluation of Medically Refractory Focal Epilepsy
T. O'Brien, K. Miles, R. Ware, M. Cook +2 more
2008Journal of Nuclear Medicine73 citations Open access
Semantic Scholar
Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method.
M. Bayne, R. Hicks, S. Everitt, N. Fimmell +6 more
2007International Journal of Radiation Oncology, Biology, Physics73 citations
Semantic Scholar
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
E. Lau, K. Drummond, R. Ware, E. Drummond +5 more
2010Journal of clinical neuroscience71 citations
Semantic Scholar
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.
V. Kalff, R. Hicks, R. Ware, A. Hogg +2 more
2002Journal of Nuclear Medicine66 citations
Semantic Scholar
18F-Flumazenil: A γ-Aminobutyric Acid A–Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy
L. Vivash, M. Grégoire, E. Lau, R. Ware +7 more
2013Journal of Nuclear Medicine60 citations Open access
Semantic Scholar
The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal--based PET scanner in the presurgical evaluation of partial epilepsy.
T. J. O'Brien, R. J. Hicks, R. Ware, D. Binns +2 more
2001Journal of Nuclear Medicine60 citations
Semantic Scholar
PET/CT: will it change the way that we use CT in cancer imaging?
R. Hicks, R. Ware, E. Lau
2006Cancer Imaging51 citations Open access
Semantic Scholar
Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses.
A. Pitman, R. Hicks, D. Binns, R. Ware +4 more
2002British Journal of Radiology37 citations
Semantic Scholar
Radiation changes do not interfere with postchemoradiation restaging of patients with rectal cancer by FDG PET/CT before curative surgical therapy.
V. Kalff, R. Ware, A. Heriot, M. Chao +2 more
2009International Journal of Radiation Oncology, Biology, Physics36 citations
Semantic Scholar
Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET
V. Kalff, R. Hicks, R. Ware, B. Greer +2 more
2002European Journal of Nuclear Medicine and Molecular Imaging31 citations
Semantic Scholar
The Australian Government's Review of Positron Emission Tomography: evidence‐based policy‐making in action
R. Ware, H. W. Francis, Kenneth E. Read
2004Medical Journal of Australia24 citations
Semantic Scholar
Total-Body PET/CT: Pros and Cons.
R. Hicks, R. Ware, J. Callahan
2024Seminars in nuclear medicine22 citations Open access
Semantic Scholar
Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?
R. Ware, R. Hicks
2011Journal of Nuclear Medicine22 citations Open access
Semantic Scholar
Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible
A. Pitman, Rodney J. Hicks, V. Kalff, D. Binns +4 more
2001Medical Journal of Australia19 citations
Semantic Scholar
Decrease in Imaging Costs
E. Lau, D. Binns, R. Ware, S. Ramdave +8 more
18 citations
Semantic Scholar
Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.
M. MacManus, Rodney J. Hicks, David Ball, F. Ciavarella +7 more
2001Australasian Radiology16 citations
Semantic Scholar
29. F-18 FDG PET for Suspected or Confirmed Regional Recurrence of Colon Cancer. A Prospective Study of Impact and Outcome.
Victor Kalff, R. Hicks, R. Ware, D. Binns +1 more
2000Clinical Positron Imaging16 citations
Semantic Scholar
Molecular Imaging of Recurrent and Metastatic Prostate Cancer.
R. Ware, S. Williams, R. Hicks
2019Seminars in nuclear medicine14 citations
Semantic Scholar
Positron emission tomography (PET): experience with a large‐field‐of‐view three‐dimensional PET scanner
Rodney J. Hicks, D. Binns, M. Fawcett, R. Ware +4 more
1999Medical Journal of Australia13 citations
Semantic Scholar
Enhanced white adipose tissue metabolism in iatrogenic Cushing's syndrome with FDG PET/CT.
D. Pattison, M. Hofman, E. Lau, R. Ware +1 more
2014Journal of Clinical Endocrinology and Metabolism12 citations
Semantic Scholar
Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET
R. Hicks, R. Ware, M. Hofman
2012Journal of Nuclear Medicine7 citations Open access
Semantic Scholar
Let's get SEERious: more accurate staging with consequent high management impact is not just stage migration.
M. Hofman, D. Ball, M. Mac Manus, R. Ware +1 more
2013Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Clinical significance of 18F-FDG PET/CT whole body imaging in detecting incidental abnormalities in cancerous patients
Guo-Hui Wang, E. Lau, R. Shakher, R. Ware +4 more
20072 citations
Semantic Scholar
Clinical Impact of PET Scanning in Patients Being Staged with Non-Small-Cell Lung Cancer (NSCLC) in a Radiation Oncology Facility.
R. Hicks, M. MacManus, V. Kalff, D. Binns +3 more
1999Clinical Positron Imaging2 citations
Semantic Scholar
On the Inclusion of Specialists as Authors in Systematic Reviews
R. Hicks, Lauren J. Hicks, R. Ware
20201 citations
Semantic Scholar
First-in-human trial of 64 Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy
R. Hicks, P. Jackson, G. Kong, R. Ware +19 more
20181 citations
Semantic Scholar
First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET)
R. Hicks, P. Jackson, R. Ware, E. Drummond +11 more
20161 citations
Semantic Scholar
Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET—Rebuttal
R. Hicks, M. Hofman, R. Ware
2013Journal of Nuclear Medicine1 citations Open access
Semantic Scholar
Health technology assessment (HTA) groups have been instrumental in restricting patient access to PET worldwide.
R. Ware
2004Journal of Nuclear Medicine1 citations
Semantic Scholar
Comments and Perspectives
R. Ware
20041 citations
Semantic Scholar
64. Fluorine F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for restaging of non-small-cell lung cancer (NSCLC): Analysis of management change and survival in 63 consecutive patients
R. Hicks, D. Binns, V. Kalff, R. Ware +5 more
20001 citations
Semantic Scholar
PET screening for metastatic colorectal adenocarcinoma.
M. Hofman, R. Ware, B. Thomson
2014Journal of the American Medical Association (JAMA)0 citations
Semantic Scholar
Non-small Cell Lung Carcinoma: 18F-fluorodeoxyglucose-Positron Emission Tomography
R. Hicks, R. Ware
20080 citations
Semantic Scholar
The Australian Government's Review of Positron Emission Tomography: evidence‐based policy decision‐making in action
R. Ware, H. W. Francis, Kenneth E. Read
20040 citations
Semantic Scholar
48. Use of 18F-FDG PET in patients with a residual abnormality following primary treatment for head and neck carcinoma: accuracy, management impact, and prognostic stratification
R. Ware, E. Lau, D. Binns, L. Peters +3 more
20010 citations
Semantic Scholar
28. Accuracy of 18F-fluorodeodeoxyglucose positron emission tomography (PET) in characterisation of indeterminate pulmonary masses: Australian experience
A. Pitman, R. Hicks, D. Binns, A. Hogg +4 more
20000 citations
Semantic Scholar
65. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for primary staging of non-small-cell lung cancer (NSCLC): Analysis of management change and survival in 153 consecutive patients
R. Hicks, D. Binns, V. Kalff, R. Ware +5 more
20000 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Hicks×37
Invite
R. Hicks — researcher profile on SciRah
A. Hogg×17
Invite
A. Hogg — researcher profile on SciRah
V. Kalff×14
Invite
V. Kalff — researcher profile on SciRah
A. McKenzie×12
Invite
A. McKenzie — researcher profile on SciRah

×12

Invite

M. MacManus — researcher profile on SciRah

Invite

D. Binns — researcher profile on SciRah

Invite

E. Lau — researcher profile on SciRah

Invite

M. Hofman — researcher profile on SciRah

Invite

E. Drummond — researcher profile on SciRah

Invite

D. Ball — researcher profile on SciRah

Invite

J. Matthews — researcher profile on SciRah

Invite

D. Binns — researcher profile on SciRah